本页面由Tiger Trade Technology Pte. Ltd.提供服务

Arcutis Biotherapeutics Inc.

23.89
+0.50502.16%
盘后23.890.00000.00%19:30 EDT
成交量:204.47万
成交额:4,889.38万
市值:29.87亿
市盈率:110.88
高:24.18
开:23.63
低:23.55
收:23.38
52周最高:31.77
52周最低:16.57
股本:1.25亿
流通股本:1.11亿
量比:0.90
换手率:1.84%
股息:- -
股息率:- -
每股收益(TTM):0.2154
每股收益(LYR):-0.1269
净资产收益率:15.86%
总资产收益率:5.09%
市净率:13.54
市盈率(LYR):-188.28

数据加载中...

2024/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/18

重要事件披露

Form 8-K - Current report
2024/06/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/14

重要事件披露

Form 8-K - Current report
2024/05/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/10

重要事件披露

Form 8-K - Current report
2024/03/06

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities